Peterson Ventures is an early-stage venture capital firm focused on SaaS, digital commerce, and healthcare. They provide seed funding to entrepreneurs looking for a partner to help solve the challenges that accompany rapid growth.

Peterson Ventures

M13 provides strategic counsel and operational expertise to help founders grow their companies. Through Fund II, M13 will expand its focus to emerging technologies driving change in consumer behavior over the next decade.   Founded in 2016 with offices in Los Angeles, New York, and San Francisco.

We are a New York City based investment firm focused on venture capital and private equity opportunities. Our team invests in technology enabled companies in the financial, consumer, healthcare, and software industries. Our portfolio companies have strong management teams characterized by integrity, intelligence, experience, energy, and passion.

Rosecliff Ventures

Ridgeline Ventures (formerly Range Light) is a venture investment firm in natural foods and active lifestyle companies.  They invest in founders and companies who are looking for more than just capital. They help healthy living brands map out their strategic vision and bring that vision to life. As former operators, they understand what it’s like to be in the trenches and they use their experience to provide strategic guidance, operating expertise, and a vast network of contacts for teams seeking a collaborative partner. They look for natural foods and active lifestyle brands with awesome teams and products they love. They are drawn to companies that are dedicated to making a difference and helping people live healthier lives. Because they invest their own capital, they have extraordinary flexibility in the size and type of investments they make, as well as the stage of the company in which they invest. They are comfortable leading investment rounds and also like to collaborate with like-minded partners.''

Ridgeline Ventures

Seaside Ventures is pioneering the future of consumer health technology, with a vision to fund the most innovative startups. Positioned within the vast $4 trillion healthcare market, we're investing in emerging technologies to address longstanding health challenges, transforming everyday lives. Our mission? To elevate the mental and physical well-being of over a billion people globally, ensuring our portfolio's products and services become integral to enhancing their quality of life.

Seaside Ventures

Lifeforce

Lifeforce operates as a clinically integrated health optimization platform.

<div>California-based Lifeforce is a health platform that allows its users to have their blood samples asynchronously interpreted by medical experts to improve a patient&rsquo;s overall health. The company&rsquo;s blood tests, extracted in person by registered phlebotomists, measure the user&rsquo;s health against over 40 biomarkers with regard to physical, cognitive, sexual, and psychological performance. Post-extraction and analysis, users can consult virtually with specialists and health coaches to develop personalized care plans that incorporate lifestyle changes, nutraceuticals, hormone, and peptide therapies.&nbsp;</div>

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

Lifeforce: This Health Optimization Company Helps Users Develop Plans And Track Progress

<div>
 
 California-based Lifeforce is a health platform that allows its users to have their blood samples asynchronously interpreted by medical experts to improve a patient&rsquo;s overall health. The company&rsquo;s blood tests, extracted in person by registered phlebotomists, measure the user&rsquo;s health against over 40 biomarkers with regard to physical, cognitive, sexual, and psychological performance. Post-extraction and analysis, users can consult virtually with specialists and health coaches to develop personalized care plans that incorporate lifestyle changes, nutraceuticals, hormone, and peptide therapies.&nbsp;
 
 
 The company&rsquo;s treatment model was created in consultation with specialists from several prominent medical institutions, such as Harvard Medical School and Cleveland Clinic, and the company is backed by influential figures, such as tennis star Serena Williams. The company operates on a subscription-basis where users are charged USD 349 for initial blood tests and biomarker screening, after which users are charged USD 129 per month for the company&rsquo;s coaching, care plan tracking, medication, and therapies.
 
 
 
 
 
 Funding and financials
 &nbsp;
 
 
 In May 2023, the company raised USD 12 million in a Series A funding round co-led by M13 and Peterson Ventures, along with participation from several other venture capital firms. M13 previously incubated Lifeforce through its in-house venture studio, &quot;Launchpad.&quot; The raised funds were set aside to expedite the company&rsquo;s growth, expand its product offerings, and reinforce its market presence. 
 
</div>

<div>
 
 Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
 
 
 In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
 
 
 
</div>

Nice Healthcare

Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications.Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.

Amicomed

Winston is a men’s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients.The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.

Winston

<div>
 
 Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
 
 
 The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care, wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
 
 
 Key Customers and partnerships
 
 
 Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
 
 
 Fundings and financials
 
 
 As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
 
 
 In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
 an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
 
 Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
 <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
 acquired by financial services company Sun Life Financial
 </a>
 for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
 
 
 
</div>

Dialogue

Grin offers telemedicine and remote monitoring services for orthodontic needs such as braces and teeth straightening. Patients can conduct self-scans (using a Grin device made available to patients in collaboration with 3M) which can be connected to their smartphones and share the feed with orthodontists to access dental solutions. The company plans to go to a subscription-based model after the pandemic. The app also encourages patients to have a 40-second check monthly and share the scan with a dentist in order to allow patients to regularly maintain their dental hygiene.Grin is the only Telehealth disruptor covered on the hub that provides virtual orthopaedic consultations.Funding and financialsIn April 2021, the New York-based teledental platform concluded a seed funding of USD 14 million, and the funds will be allocated to develop additional functionalities by building out its technology. The proceeds will also be used to scale up its team, expand its geographic footprint, and add doctors to the company’s orthodontic partner network.

Grin

Real-time collection of patients’ health-related data using any remote patient monitoring device combined with general telemedicine services to reduce readmission rates. 


A platform that facilitates the transmission of patient data to different locations for further evaluation and interpretation by medical specialists. 


A digital platform that offers specialty care services to address the specific needs of a patient or demographic, including consultations where patients are generally reluctant to meet practitioners face-to-face.

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app. 

Companies developing B2B software solutions for patient engagement, care navigation, practice management, and electronic health records integration to facilitate telehealth services for healthcare providers. 

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

Lifeforce

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless